August 31, 2018 Interview with our Federico Pollano

Combining established and novel technologies

Last year, Rentschler Biopharma SE formed a strategic alliance with formulation specialist Leukocare AG. European Biotechnology spoke with Federico Pollano about the impact Leukocare’s SPS® technology will have on the market and how Rentschler Biopharma combines tried-and-tested technologies with new innovations to lead the CDMO market.

Please find the full interview here.